Cargando…
Teriflunomide attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations
BACKGROUND: Genetically caused neurological disorders of the central nervous system (CNS) are mostly characterized by poor or even fatal clinical outcome and few or no causative treatments are available. Often, these disorders are associated with low-grade, disease-promoting inflammation, another fe...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031103/ https://www.ncbi.nlm.nih.gov/pubmed/29970109 http://dx.doi.org/10.1186/s12974-018-1228-z |